Wolf IH, et al. Dermoscopic classification of atypical melanocytic nevi (Clark nevi). Arch Dermatol. 2001;137(12):1575-1580. 3. Rieger E, Kofler R, Borkenstein M, Schwingshandl J, Soyer HP, Kerl H. Melanotic macules following Blaschko's lines in McCune-Albright syndrome. Br J Dermatol. 1994;130(2):215-220. 4. Quatresooz P, Hermanns JF, Hermanns-Le T, Pierard GE, Nizet JL. Laddering melanotic pattern of Langer's lines in skin of colour. Eur J Dermatol. 2008; 18(5):575-578. 5. Langer K. On the anatomy and physiology of the skin, I: the cleavability of the cutis. Br J Plast Surg. 1861;31(1):3-8.
A Comparison of High-and Low-Cost Infection-Control Practices in Dermatologic Surgery
T hough several studies have examined infection risk in dermatologic surgery, studies comparing costs of different infection control protocols are lacking. This study was undertaken to determine whether a low risk of infection could be maintained with a low-cost infection-control protocol.
Methods.
A prospective study of 573 consecutive patients with 670 tumors undergoing Mohs surgery with same-day reconstruction or second-intention healing evaluated whether a low rate of surgical site infection (SSI) could be maintained with a low-cost infection-control protocol. Surgical site infections were tracked from January through September 2010 in a single-surgeon academic Mohs practice (termed low-cost group), and these were compared with those from a previously published group of 585 cases in which the infection rate had dropped from 2.5% (the practice's initial infection rate) to 0.9% with initiation of a more stringent but expensive infectioncontrol protocol (high-cost group). 1 The infectioncontrol protocols investigated are summarized in Table 1 . The study was approved by the Partners Human Research Office.
Infection was defined as any case in which antibiotic therapy was used for suspected wound infection. Criteria for determining the presence of infection and initiating antibiotic therapy are summarized in the Figure. Patients were seen for suture removal or for wound check (in cases of second-intention healing) at postoperative day 7 to 10. The presence or absence of infection was assessed at this visit. In addition, all patients were given an instruction sheet on the day of surgery describing symptoms of infection (redness, pain, swelling, fever, or pus) with instructions to come to the office for evaluation if these symptoms occurred. Wounds were cultured before antibiotic therapy was begun in all cases.
Surgical skin preparation differed between groups because chloroxylenol, 3%, became commercially unavailable during the study period. This likely had little impact on results because the efficacy of chloroxylenol and iodine skin preparations are reportedly equivalent. 2 There were no personnel changes, and resident participation was consistent (approximately 20% of cases) between the groups.
Potential confounders that differed significantly on 2 test results between infection control protocol groups were tested for association with the primary study outcome (presence or absence of infection) via the Fisher exact test. Statistical significance was set at P Ͻ.05 (STATA 9; StataCorp LP).
The cost of infection control per case was calculated by tabulating the costs of infection-control protocols for a 1-stage Mohs procedure and reconstruction performed by 1 surgeon and 1 assistant ( Table 1 ). The cost per infection prevented was calculated by dividing the cost of infection control per case by the reduction in infection risk from the baseline risk of 2.5%.
Results. Patients in the low-cost group were statistically different from those in the high-cost group with regard to several variables ( Table 2 ). However, none of these variables was significantly associated with infection on Fisher exact testing (data not shown), indicating that there was no confounding of infection risk due to these between-group differences.
Infection risk was the same between high-cost (n=5, 0.9%) and low-cost groups (n = 5, 0.7%). The cost of infection control per case was lowered from $14.62 in the high-cost group to $6.22 in the low-cost group. Compared with the baseline cost of $3.76 and infection risk of 2.5% previously published, 1 the high-cost group had a $10.86 cost increase per case and a 1.6% drop in infection risk, whereas the low-cost group had a $2.46 increase in cost and a 1.8% drop in infection risk. This corresponds to a cost per infection prevented of $678.75 for the high-cost group and $136.67 for the low-cost group ($10.86/0.016 and $2.46/0.018, respectively).
Comment. This study indicates that low-cost infectioncontrol protocols can be implemented without impacting infection risk in office-based Mohs surgery. The cost per infection prevented was reduced to $136.67, which is likely cost-effective, since the costs associated with diagnosing and treating surgical site infections (including physician time, patient time and discomfort, and costs of wound cultures and antibiotic therapy) exceed this amount.
Infection-control costs were reduced by eliminating sterile gloves during Mohs stages, and sterile gowns and half-sheet drapes during reconstruction. It may be possible to further reduce costs without altering infection rate by using clean, nonsterile gloves during reconstruction as well. 3, 4 Since infection risks for Mohs and general dermatologic surgery are similarly low, 5 the lowcost infection-control protocol described herein may be applicable to all office-based dermatologic surgery.
The major limitation of this study is its singlesurgeon practice setting. There may be factors unique to this study site or staff that are not generalizable to oth- ers. In addition, since the 3 changes in the low-cost protocol were made simultaneously, the impact of each individual change cannot be evaluated. However, infectioncontrol measures are frequently implemented and studied as regimens involving several elements. A randomized, multicenter trial comparing infection regimens would eliminate the possibility of bias from use of historical controls and enhance generalizability of results. Such studies are needed to define optimally cost-effective infection-control protocols in the dermatologic surgery patient population. With regard to demographic factors, the rate of PSE was lower among men, younger individuals, and those with a lower education level, but the rate did not differ across region of residence. The rate of PSE was lower among individuals who had no source of preventive care or who received preventive care somewhere other than a physician's office or health maintenance organization. Individuals lacking health care coverage also had lower rates of PSE. Participants reporting less sun-sensitive skin had lower rates of PSE than those with the most sensitive skin. The rate of PSE did not differ according to the number of reported sunburns in the past year.
Results. As listed in the
Comment. Only 1 in 14 US Hispanic adults in the present study reported ever having a PSE, which is lower than the 1 in 4 rate (25.4%) among non-Hispanic white adults in the 2010 NHIS. Based on their reported nativity and language use, more-acculturated Hispanics had a higher rate of PSE. Prior research has found mixed evidence regarding the association between acculturation among US Hispanics and skin cancer-related behaviors, with more acculturated individuals having higher rates of sunscreen use but lower rates of staying in the shade and wearing sun-protective clothing. 4 Differences in the rate of PSE across individuals' levels of acculturation and Hispanic origin in the current study highlight the need for future research to explore concomitant differences in skin cancer prevention knowledge, attitudes, and beliefs. 
